John Schmidt, MD
Physical Medicine & Rehabilitation · Cary, NCNPI 1467863076
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.6% of the total across 145 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by Medtronic at 31.8% of the total. 2025 is the largest year on record at $1,842, more than ten times the $22 reported in 2019.
Across 145 payments — averaging $36.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Biotronik NRO, Inc.$842
- Collegium Pharmaceutical, Inc.$473
- Boston Scientific$441
- Scilex Pharmaceuticals Inc.$372
- Globus Medical$360
- plus $1K from 18 others
What the payments were for
- Travel & lodging$2645%
- Food & beverage$4,98195%
- Education$210%
- Gifts$00%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 27 | $1,675 |
| Biotronik NRO, Inc. | 13 | $842 |
| Collegium Pharmaceutical, Inc. | 26 | $473 |
| Boston Scientific | 10 | $441 |
| Scilex Pharmaceuticals Inc. | 18 | $372 |
| Globus Medical | 5 | $360 |
| Abbott | 3 | $216 |
| Averitas Pharma Inc. | 5 | $152 |
| Nevro Corp. | 7 | $148 |
| Forte Bio-pharma LLC | 6 | $136 |
| Radius Health, Inc. | 2 | $55 |
| Biodelivery Sciences International, Inc. | 4 | $52 |
| IBSA Pharma Inc. | 3 | $51 |
| Vertex | 2 | $49 |
| Si-bone, Inc. | 2 | $36 |
| Arbor Pharmaceuticals, Inc. | 2 | $34 |
| Azurity Pharmaceuticals, Inc. | 2 | $34 |
| Avanos Medical | 2 | $32 |
| Daiichi Sankyo Inc. | 1 | $27 |
| Hikma Pharmaceuticals USA | 1 | $21 |
| Amgen | 1 | $18 |
| Virtus Pharmaceuticals LLC | 1 | $17 |
| Johnson & Johnson | 1 | $14 |
| Stimwave Technologies Incorporated | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$553
- Prospera$385
- KYPHON Balloon Kyphoplasty$382
- Senza$291
- INCEPTIV$160
- ETERNA$149
- KYPHON EXPRESS II KYPHOPAK TRAY$107
How this compares
$5,267 in reported general payments places this provider in the 85th percentile of 269 physical medicine & rehabilitation providers in North Carolina.
See all physical medicine & rehabilitation providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 475 | $56,645 |
| BelbucaBuprenorphine Hcl | 61 | $51,294 |
| ZtlidoLidocaine | 36 | $35,639 |
| Lidocaine | 156 | $31,435 |
| Buprenorphine | 96 | $22,960 |
| Xtampza ErOxycodone Myristate | 24 | $14,478 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 284 | $7,438 |
| LinzessLinaclotide | 11 | $5,740 |
| Gabapentin | 487 | $5,608 |
| Pregabalin | 248 | $3,558 |
| Oxycodone Hcl | 229 | $3,532 |
| Diclofenac Sodium | 80 | $2,622 |
| Baclofen | 209 | $1,847 |
| Morphine Sulfate ErMorphine Sulfate | 42 | $1,401 |
| Tramadol Hcl ErTramadol Hcl | 14 | $1,165 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $473 | $65,77285 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $372 | $35,63936 claims |
| Hikma Pharmaceuticals USABuprenorphine, Morphine Sulfate | $21 | $23,455119 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 269 physical medicine & rehabilitation providers in North Carolina.
Other physical medicine & rehabilitation in Cary
- Christopher GodboutCary$12K
- Paul AndrewsCary$11K
- Peng BaiCary$5K
- Nicole BullockCary$3K
- Andrew SumichCharlotte$181K
- Patrick O BrienRaleigh$86K
- Elizabeth BagsbyGreenville$33K
- Krishna BhatSanford$30K
- Jasbir DhaliwalSanford$23K
- Jimmy MaliDurham$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.